VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PBHPrestige Consumer Healthcare Inc.
$49.41$2.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPBHBalance Sheet

Prestige Consumer Healthcare Inc. (PBH) Balance Sheet

26Y historyFree accessUpdated daily

The company has successfully deleveraged its balance sheet, reducing total debt from $1.2 billion in 2024Q3 to $1.0 billion by 2026Q4, though goodwill remains a significant asset concentration at $581.1 million.

PBH Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01
Total Current Assets431.48M448.33M375.04M391.74M293.27M269.83M365.65M300.94M303.48M334.43M249.01M201.71M177.19M164.17M147.03M107.58M112.15M103.56M85.38M83.77M86.01M79.66M30.75M3.53M7.88M0
Cash & Short-Term Investments63.87M97.88M46.47M58.49M27.18M32.3M94.76M27.53M32.55M41.85M27.23M21.32M28.33M15.67M19.02M13.33M41.1M35.18M6.08M13.76M8.2M5.33M3.39M3.53M7.88M0
Cash Only63.87M97.88M46.47M58.49M27.18M32.3M94.76M27.53M32.55M41.85M27.23M21.32M28.33M15.67M19.02M13.33M41.1M35.18M6.08M13.76M8.2M5.33M3.39M3.53M7.88M0
Short-Term Investments00000000000000000000000000
Accounts Receivable191.92M194.29M176.78M167.02M139.33M114.67M150.52M148.79M140.88M136.74M95.25M87.86M65.05M73.05M60.23M44.39M30.62M36.02M44.22M35.17M40.04M35.92M15.73M000
Days Sales Outstanding64.3462.3357.3454.0646.7944.3757.0555.6649.3956.5843.1244.8739.4542.7649.8448.1537.0142.0549.4240.2849.2643.2265.31---
Inventory159.13M147.71M138.72M162.12M120.34M114.96M116.03M119.88M118.55M115.61M91.26M74M65.59M60.2M51.11M39.75M29.16M26.98M29.7M30.17M33.84M21.58M9.75M000
Days Inventory Outstanding112.99107.12101.08117.7894.23105.99103.09104.1393.12110.5398.2587.5891.4379.587.387.673.6265.8968.5671.9188.5955.7398.08---
Other Current Assets16.56M8.44M13.08M4.12M0004.74M040.23M10.11M8.1M6.54M6.35M5.28M10.1M11.27M5.38M3.07M2.73M3.93M8.85M1.65M000
Total Non-Current Assets3.12B2.95B2.94B2.96B3.38B3.16B3.15B3.14B3.46B3.58B2.7B2.47B1.62B1.58B1.61B949.34M679.26M697.82M963.78M979.65M952.63M921.48M295.87M000
Property, Plant & Equipment171.25M127.84M89.33M89.53M98.53M102.77M90.72M51.18M52.55M50.59M15.54M13.74M9.6M9.9M1.3M1.44M1.4M1.37M1.43M1.45M1.65M2.32M880K000
Fixed Asset Turnover6.36x8.90x12.60x12.60x11.03x9.18x10.62x19.07x19.81x17.43x51.88x52.00x62.72x63.02x338.26x233.04x216.35x228.76x227.92x219.90x179.47x130.52x99.91x---
Goodwill581.11M527.42M527.73M527.55M578.98M578.08M575.18M578.58M620.1M615.25M360.19M290.65M190.91M167.55M173.7M154.9M111.49M114.24M308.92M310.95M297.94M055.59M000
Intangible Assets2.3B2.3B2.32B2.34B2.7B2.48B2.48B2.51B2.78B2.9B2.32B2.13B1.39B1.37B1.4B786.36M559.23M577.59M646.68M657.16M637.2M294.54M0000
Long-Term Investments0000000-399.57M-26K-715.09M-10.11M-8.1M-6.54M-6.35M-5.28M-5.29M-6.35M-4.02M-3.07M-2.73M-3.23M-5.7M0000
Other Non-Current Assets2.17M3.27M5.72M3M3.27M2.86M2.96M3.13M3.57M7.45M1.32M28.6M23.15M24.94M35.71M6.63M7.15M4.62M6.75M10.1M15.85M624.61M239.39M000
Total Assets3.55B3.4B3.32B3.35B3.67B3.43B3.51B3.44B3.76B3.91B2.95B2.67B1.8B1.74B1.76B1.06B791.41M801.38M1.05B1.06B1.04B1B326.62M142.06M174.04M151.29M
Asset Turnover0.31x0.33x0.34x0.34x0.30x0.28x0.27x0.28x0.28x0.23x0.27x0.27x0.34x0.36x0.25x0.32x0.38x0.39x0.31x0.30x0.29x0.30x0.27x0.50x0.27x0.06x
Asset Growth %4.27%2.53%-1.05%-8.63%7.04%-2.41%2.12%-8.5%-3.85%32.64%10.47%48.66%3.21%-1.05%66.36%33.55%-1.24%-23.62%-1.34%2.38%3.75%206.51%129.92%-18.38%15.04%-
Total Current Liabilities120.92M106.62M117.05M160.72M143.42M122.14M149.88M126.98M123.2M162.01M106.68M99.04M84.36M96.67M63.92M54.21M55.65M34.23M37.89M40.91M35.73M38.91M14.54M000
Accounts Payable22.79M18.93M38.98M62.74M55.76M45.98M62.38M56.56M61.39M70.22M38.3M46.12M48.29M51.38M26.73M21.61M12.77M18.05M20.54M19.3M18.07M21.7M5.28M000
Days Payables Outstanding16.1813.7228.445.5843.6642.3955.4249.1348.2267.1341.2354.5867.3167.8545.6547.6332.2444.0847.4246.0147.2956.0553.13---
Short-Term Debt12.55M00000000000000029.59M3.55M3.55M3.55M3.73M3.73M2M000
Deferred Revenue (Current)000000000492K000000000012.14M-3.73M-2M000
Other Current Liabilities72.72M14.21M57.13M14.29M19.59M14.07M13.39M88K1.9M22.84M11.31M4.33M3.11M35.95M29.44M25M8.06M11.2M0011.08M9.4M0000
Current Ratio3.57x4.20x3.20x2.44x2.04x2.21x2.44x2.37x2.46x2.06x2.33x2.04x2.10x1.70x2.30x1.98x2.02x3.03x2.25x2.05x2.41x2.05x2.11x---
Quick Ratio2.25x2.82x2.02x1.43x1.21x1.27x1.67x1.43x1.50x1.35x1.48x1.29x1.32x1.08x1.50x1.25x1.49x2.24x1.47x1.31x1.46x1.49x1.44x---
Cash Conversion Cycle161.15155.73130.01126.2597.36107.97104.72110.6694.2899.98100.1477.8863.5754.4191.4988.1278.3863.8570.5666.1990.5642.9110.26---
Total Non-Current Liabilities1.54B1.46B1.55B1.75B1.95B1.95B2.19B2.22B2.46B2.93B2.1B1.94B1.15B1.17B1.29B640.88M406.7M472.77M532.19M577.17M593.5M576.38M185.57M000
Long-Term Debt993.95M992.36M1.13B1.35B1.48B1.48B1.73B1.8B1.99B2.19B1.63B1.59B934.41M970.9M1.12B486.94M294.56M374.79M407.68M459.8M494.9M491.63M146.69M000
Capital Lease Obligations38.92M43.36M7.7M11.54M20.59M26.52M29.5M0000000000000000000
Deferred Tax Liabilities500.67M419.59M403.6M380.43M444.92M434.05M407.81M399.57M442.52M715.09M469.62M351.57M213.2M194.29M167.72M153.93M112.14M97.98M122.14M114.57M98.6M84.75M38.87M000
Other Non-Current Liabilities5.58M5.39M9.19M8.16M7.48M8.61M25.44M20.05M23.33M17.97M2.84M2.46M327K000002.38M2.8M000000
Total Liabilities1.66B1.57B1.66B1.91B2.09B2.07B2.34B2.35B2.58B3.09B2.2B2.04B1.23B1.26B1.36B695.09M462.35M507M570.08M618.08M629.24M615.29M200.11M98.2M115.3M105.26M
Total Debt1.05B1.04B1.14B1.37B1.51B1.51B1.77B1.8B1.99B2.19B1.63B1.59B934.41M970.9M1.12B486.94M324.14M378.34M411.23M463.35M498.63M495.36M148.69M000
Net Debt981.56M946.37M1.09B1.31B1.48B1.48B1.67B1.77B1.96B2.15B1.6B1.57B906.08M955.23M1.1B473.61M283.05M343.16M405.15M449.59M490.43M490.03M145.3M-3.53M-7.88M0
Debt / Equity0.55x0.57x0.69x0.94x0.95x1.12x1.51x1.64x1.69x2.67x2.18x2.53x1.66x2.03x2.79x1.35x0.99x1.29x0.86x1.04x1.22x1.28x1.18x---
Debt / EBITDA3.07x2.85x3.05x133.90x4.16x4.62x5.37x18.12x7.99x9.48x5.72x7.05x4.62x4.73x9.90x5.65x3.52x-3.90x4.28x5.12x4.66x6.69x---
Net Debt / EBITDA2.88x2.58x2.93x128.17x4.09x4.53x5.08x17.84x7.86x9.30x5.63x6.96x4.48x4.66x9.73x5.49x3.07x-3.84x4.15x5.04x4.61x6.54x-0.11x-0.42x-
Interest Coverage7.31x6.97x5.11x-0.36x5.08x3.48x2.98x0.64x3.03x2.18x2.84x2.57x2.48x2.26x2.48x2.78x3.30x-5.92x--------
Total Equity1.89B1.83B1.66B1.45B1.58B1.36B1.17B1.1B1.18B822.55M744.34M627.62M563.36M477.94M402.73M361.83M329.06M294.38M479.07M445.33M409.41M385.85M126.51M43.86M58.74M46.03M
Equity Growth %2.87%10.86%14.37%-8.27%16.15%16%6.86%-7.02%43.29%10.51%18.6%11.41%17.87%18.68%11.3%9.96%11.78%-38.55%7.58%8.78%6.11%204.99%188.45%-25.33%27.61%-
Book Value per Share38.7436.6432.9829.0131.0326.8422.9021.0522.0215.4114.0111.9210.769.297.947.196.575.909.578.908.1914.014.760.882.131.73
Total Shareholders' Equity1.89B1.83B1.66B1.45B1.58B1.36B1.17B1.1B1.18B822.55M744.34M627.62M563.36M477.94M402.73M361.83M329.06M294.38M479.07M445.33M409.41M385.85M126.51M43.86M58.74M46.03M
Common Stock562K560K555K548K544K540K538K536K534K533K530K525K520K513K505K503K502K501K501K501K501K500K0000
Retained Earnings1.75B1.56B1.34B1.13B1.21B1.01B844.1M701.82M736.28M396.71M327.31M227.41M149.15M76.25M10.74M-26.19M-55.41M-87.52M99.25M65.33M29.26M6.78M1.79M000
Treasury Stock-439.3M-277.21M-219.62M-189.11M-133.65M-130.73M-117.62M-59.93M-7.67M-6.59M-5.16M-3.48M-1.43M-687K-687K-416K-63K-63K-47K-40K-30K-4K0000
Accumulated OCI-28.37M-37.66M-34.49M-31.56M-19.03M-19.8M-44.16M-25.75M-19.32M-26.35M-23.52M-23.41M739K-104K-13K-2.77M-2.45M-1.33M-999K313K1.11M320K0000
Minority Interest00000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Goodwill impairment and leverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Deleveraging Amidst Stagnant Asset Growth

According to reported balance sheet data, PBH has successfully reduced its total debt from $1.2 billion in 2024Q3 to $1.0 billion by 2026Q4, signaling a strategic shift toward balance sheet consolidation as the company navigates a period of persistent organic revenue contraction and limited asset expansion.

The reduction in debt levels alongside a stable equity base suggests management is prioritizing financial flexibility over aggressive acquisition-led growth. This trajectory implies a defensive posture, likely intended to preserve credit quality while the core business faces headwinds in maintaining its historical market share.

Strategic Debt Reduction Enhances Stability

Based on the latest quarterly filings, the company's debt-to-equity ratio has improved from 0.76 in 2024Q3 to 0.55 in 2026Q4, reflecting a disciplined approach to capital structure management that appears designed to mitigate interest rate sensitivity in a challenging consumer healthcare environment.

The consistent paydown of debt obligations suggests that the company is utilizing its free cash flow to deleverage rather than pursuing further debt-funded M&A. Investors should monitor whether this trend continues, as it may indicate a lack of attractive acquisition targets or a pivot toward organic growth initiatives.

Intangible Concentration Risks Asset Quality

As reported in financial statements, goodwill accounts for a significant portion of the $3.5 billion total asset base, with the figure rising from $527.9 million in 2024Q3 to $581.1 million in 2026Q4, highlighting a heavy reliance on acquired brand equity to support the company's valuation.

The high concentration of intangible assets warrants close scrutiny, as any sustained decline in the performance of core brands could necessitate non-cash impairment charges. While the asset-light model is efficient, the reliance on these book values may mask underlying volatility in the actual market value of the portfolio.

Robust Liquidity Buffers Against Volatility

Based on the provided financial data, the company maintains a strong liquidity profile with a current ratio of 3.57 as of 2026Q4, providing a substantial buffer against short-term operational shocks despite the recent fluctuations in cash balances observed over the last ten quarters.

The elevated current ratio suggests that the company is well-positioned to meet its short-term obligations without needing to access external financing. This liquidity cushion appears sufficient to support ongoing marketing and promotional activities, which are critical for defending shelf space in a competitive retail landscape.

Retained Earnings Drive Equity Growth

According to recent SEC filings, the company's equity base has expanded from $1.6 billion in 2024Q3 to $1.9 billion in 2026Q4, primarily driven by the consistent accumulation of retained earnings, which underscores the firm's ability to generate internal capital despite the current top-line growth challenges.

The steady growth in retained earnings reflects a disciplined reinvestment strategy that has successfully bolstered the company's net worth over time. This trend suggests that the business remains fundamentally profitable, even if the pace of revenue expansion has decelerated in recent reporting periods.

PBH — Frequently Asked Questions

Quick answers to the most common questions about buying PBH stock.

What are the total assets of Prestige Consumer Healthcare Inc. (PBH)?

As of 2026, Prestige Consumer Healthcare Inc. (PBH) had total assets of $3.55B including $431.5M in current assets.

How much debt does Prestige Consumer Healthcare Inc. (PBH) have?

Prestige Consumer Healthcare Inc. (PBH) carries total debt of $1.05B, offset by $63.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Prestige Consumer Healthcare Inc.?

Prestige Consumer Healthcare Inc. (PBH) has total shareholders' equity (book value) of $1.89B ($38.74 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Prestige Consumer Healthcare Inc.'s current ratio and liquidity?

Prestige Consumer Healthcare Inc. (PBH) reported a current ratio of 3.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.